Bolt Biotherapeutics Appoints Sheila Gujrathi as Director and Chief Strategy Officer

Bolt Biotherapeutics appointed Sheila Gujrathi to its board and as chief strategy officer, effective October 23, 2026, after the First Effective Time under the Merger Agreement.